Metabolic syndrome observation on a regional basis - ORSA Umbria
Study identifier:NIS-CIT-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Osservatorio Regionale sulla Sindrome metabolicA
Medical condition
Metabolic Syndrome
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1600
Study type
Observational
Age
18 Years - 75 Years
Date
Study Start Date: 01 Oct 2009
Primary Completion Date: 01 Oct 2010
Study Completion Date: 01 Oct 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Mario Mangrella
AstraZeneca S.p.A., R&D
